Chapter 2: Dyspnea (COPD) Flashcards
Tx for acute COPD exacerbations
Abx, Bronchodilators, ICS
Interventions to reduce COPD exacerbations
Smoking cessation
Long-acting bronchodilators
ICS
Influenza and Pneumococcal polysaccharide vaccinations
Chronic bronchitis
Cough and sputum production on most days for at least 3 months during at least 2 consecutive years
Emphysema
Shortness of breath caused by the enlargement of respiratory bronchial and alveoli caused by destruction of lung tissue
Changes in FVC and FEV1 in COPD
Both FVC and FEV1 are reduced and the ratio is less than 70%
Reversibility is defined as an increase in FEV1 of greater than 12% or 200mLq
How to measure severity of exacerbation
history (# of previous episodes/hospitalizations, other chronic conditions, current meds, h/o intubation/mech vent, duration/any new sxs)
examination (use of respiratory muscles, worsening/new cyanosis, unstable vitals, AMS, peripheral edema)
pulse ox (target of 88-92%)
PaO2 (around 60 mmHg)
Who are hospitalized
Severe symptoms Comorbidities AMS Inability to care for themselves at home Symptoms fail to respond w/ tx
If hospitalized, what should be ordered?
baseline ABG (look for hypercapnia, hypoxemia, and respiratory acidosis)
Consider vent support if conditions continue to deteriorate
Tx for acute exacerbations
short-acting bronchodilators (beta-agonist, anticholinergic)
Systemic steroids can shorten the course of exacerbation and may reduce the risk of relapse (40mg prednisolone for 10 to 14 days)
When to use abx?
Exacerbations associated with increased sputum or with purulent sputum should be treated with abx
Sputum Cx should also be performed.
Pneumococcus, H. Influ, Moraxella are MC
Klebsiella, Pseudomonas in severe exacerbations
relative young pt (<45yo), no smoking hx, PFT shows obstructive process, dx?
alpha1-antitrypsin deficiency
Mild COPD (findings and treatment)
FEV1/FVC <70%
FEV1 >80%
Short-acting bronchodilators (albuterol)
Moderate COPD (findings and treatment)
FEV1/FVC <70%
FEV1 50-80%
SABA + Long-acting bronchodilators (tiotropium)
Severe COPD (findings and treatment)
FEV1/FVC <70%
FEV1 30-50%
SABA + LABA + ICS (fluticasone)
Very severe COPD (findings and treatment)
FEV1/FVC <70%
FEV1 <30%
FEV1 <50% with chronic hypoxemia
Long-term oxygen therapy and consider surgical intervetnions